Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karin Walker Insider Profile
4 Followers
Karin Walker, CAO at Prothena, holds 0.00 shares in Prothena (Ticker: PRTA), holds 40.60K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 0.00 shares in Affymax (Ticker: AFFY). Most recently, Karin Walker Bought ― shares of Prothena on Jan 24, 2024 for an estimated value of 67.65K.
Profitable Transactions
8 out of 27 Profitable Transactions
Average Return
-5.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karin Walker holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karin Walker
Karin Walker's Trading History
Prothena
Jan 24, 2024
CAO
Informative Buy
67.65K
$0.00
Cyclacel Pharmaceuticals
Jul 03, 2023
Director
Uninformative Buy
―
$71.05K
Affymax
―
VP, Finance & CAO
―
$0.00
List of latest transactions for each holding click on a transaction to see Karin Walker's performance on stock
You May Also Like
Karin Walker insider profile FAQ
What is the percentage of profitable transactions made by Karin Walker?
The percentage of profitable transactions made by Karin Walker is 30%.
What is the average return per transaction made by Karin Walker?
The average return per transaction made by Karin Walker is -5.30%.
What stocks does Karin Walker hold?
Karin Walker holds: PRTA, CYCC, AFFY stocks.
What was Karin Walker’s latest transaction?
Karin Walker latest transaction was an Informative Buy of $67.65K.
What was Karin Walker's most profitable transaction?
Karin Walker’s most profitable transaction was an Informative Buy of PRTA stock on December 11, 2014. The return on the trade was 260.30%.
What is Karin Walker's role in Prothena?
Karin Walker's role in Prothena is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.